ImmuCell Co. Short Interest Update
| ICCC Stock | USD 3.70 0.04 1.07% |
About 67% of ImmuCell's investor base is looking to short. The analysis of overall sentiment of trading ImmuCell stock suggests that many investors are alarmed at this time. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
ImmuCell |
ImmuCell Co. was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 11,700 shares, a growth of 37.6 percent from the September 15th total of 8,500 shares. Approximately 0.3 percent of the companys shares are sold short. Based
Read at thelincolnianonline.com
 |
ImmuCell Fundamental Analysis
We analyze ImmuCell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmuCell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmuCell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
ImmuCell is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
ImmuCell Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.
Peers
ImmuCell Related Equities
| ONTTF | Oxford Nanopore | 16.88 | ||||
| PTIX | Protagenic Therapeutics | 12.31 | ||||
| LCTX | Lineage Cell | 7.02 | ||||
| FENC | Fennec Pharmaceuticals | 6.71 | ||||
| TPST | Tempest Therapeutics | 2.17 | ||||
| MNOV | MediciNova | 1.46 | ||||
| CVKD | Cadrenal Therapeutics, | 1.11 | ||||
| ACOGF | Alpha Cognition | 0.17 | ||||
| XOMAO | XOMA | 0.08 | ||||
| TRGNF | Transgene | 0.00 | ||||
| ELYM | Eliem Therapeutics | 1.32 | ||||
| RZLT | Rezolute | 1.44 | ||||
| ANEB | Anebulo Pharmaceuticals | 4.11 | ||||
| LIPO | Lipella Pharmaceuticals | 5.41 | ||||
| HCWB | HCW Biologics | 8.20 |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |